ArticleClinical & translational immunology2023

Enhanced and complementary benefits of a nalfurafine and fingolimod combination to treat immune-driven demyelination.

Katharina Robichon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.